Rakuten Investment Management Inc. Makes New $7.45 Million Investment in Agilent Technologies, Inc. $A

Rakuten Investment Management Inc. acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A) during the 3rd quarter, HoldingsChannel reports. The institutional investor acquired 58,021 shares of the medical research company’s stock, valued at approximately $7,447,000.

Several other large investors have also added to or reduced their stakes in A. Capital A Wealth Management LLC lifted its holdings in shares of Agilent Technologies by 10,600.0% during the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after purchasing an additional 212 shares during the period. Davis Capital Management acquired a new position in Agilent Technologies in the 3rd quarter worth approximately $28,000. State of Wyoming purchased a new position in Agilent Technologies during the 2nd quarter worth approximately $35,000. SJS Investment Consulting Inc. lifted its stake in Agilent Technologies by 2,836.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock valued at $41,000 after acquiring an additional 312 shares during the period. Finally, Salomon & Ludwin LLC boosted its holdings in shares of Agilent Technologies by 242.5% in the 3rd quarter. Salomon & Ludwin LLC now owns 363 shares of the medical research company’s stock valued at $51,000 after acquiring an additional 257 shares during the last quarter.

Agilent Technologies Price Performance

NYSE:A opened at $138.66 on Friday. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $160.27. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $39.31 billion, a PE ratio of 30.34, a price-to-earnings-growth ratio of 4.06 and a beta of 1.29. The stock’s 50-day moving average price is $143.60 and its 200-day moving average price is $133.85.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. The company had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.Agilent Technologies’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be given a dividend of $0.255 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is 22.32%.

Insiders Place Their Bets

In related news, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the sale, the vice president owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. The trade was a 8.61% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Padraig Mcdonnell sold 911 shares of the company’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total transaction of $130,491.64. Following the transaction, the chief executive officer owned 32,058 shares of the company’s stock, valued at $4,591,987.92. This represents a 2.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 16,401 shares of company stock worth $2,468,962 in the last three months.

Analysts Set New Price Targets

A has been the subject of several recent research reports. TD Cowen raised their target price on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Citigroup increased their price target on Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a research report on Tuesday, November 25th. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. Finally, Robert W. Baird lifted their price target on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research report on Tuesday, November 25th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $164.50.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.